Ishihara, Hisamitsu
Yamaguchi, Susumu
Nakao, Ikko
Sakatani, Taishi
Clinical trials referenced in this document:
Documents that mention this clinical trial
Ipragliflozin Add-on Therapy to a GLP-1 Receptor Agonist in Japanese Patients with Type 2 Diabetes (AGATE): A 52-Week Open-Label Study
https://doi.org/10.1007/s13300-018-0455-8
Funding for this research was provided by:
Astellas Pharma
Article History
Received: 13 February 2018
First Online: 20 June 2018